read more

first_img News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read more News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more News | March 01, 2009 ASTRO Applauds Obama Plan to Close Self-Referral Loopholes March 2, 2009 – The American Society for Radiation Oncology (ASTRO) applauds President Obama’s healthcare reform plan to double funding for cancer research and close loopholes that are weakening the Medicare program.ASTRO believes that the integrity of the Medicare program and quality patient care is being compromised by loopholes in the physician self-referral law – or Stark Law. One particular loophole, called the in-office ancillary exception (IOAE), has become the “loophole that has swallowed the rule”.”There is evidence that some physicians are using the ancillary exception to drop ‘turn-key’ radiation therapy services into group practices to maximize profit. We are afraid these arrangements compromise the quality of care, limit access, constrain patient choice from the full range of treatment options and result in overutilization of certain treatments,” said Laura I. Thevenot, ASTRO’s CEO. “ASTRO is committed to working with President Obama and Congress to prevent profit-motivated self-referrals and preserve the independent judgment and choice that patients deserve in making life and death decisions.”ASTRO is asking President Obama and Congress to close the IOAE loophole and responsibly address abuses of the self-referral law. By taking these actions, it believes budgetary savings may result that help advance the President’s healthcare priorities. For instance, savings could help increase funding for cancer research or expand coverage, both of which are critical to keep people healthy, save lives and stimulate the economy.ASTRO strongly supports comprehensive healthcare reform and looks forward to working with the President and Congress to expand coverage of the uninsured, double funding for life-saving cancer research, and strengthen Medicare by fixing its physician payment system and protecting the program’s integrity.ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information: www.astro.org FacebookTwitterLinkedInPrint分享 Catalyst PT image courtesy of C-RAD The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more Related Content News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more last_img

Leave a Reply

Your email address will not be published. Required fields are marked *